Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
<i>BRCA</i> Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
PaperCitations, authors & open-access status
<i>BRCA</i> Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 439 citations, 2018 year and closed oa status.
439
Citations
2018
Year
closed
OA Status